Adjustments for Non-Cash Items (USD)

Stock-Based Compensation (USD)

Changes in Working Capital (USD)

Capital Expenditures (CapEx) (USD)

Proceeds from / Repayments of Debt (USD)

Share Repurchases (USD)

Dividend Payments (USD)

Net Change in Cash (USD)

90aa209c466990c532db3739e21351ed316191c8aa14eda7e6bf6406ab9d123f

62a0f2aa40f4cbe3f58b00e72f437be7fad7c92fed1062f0c30eef744b910698

bb86f7740ea549db2689e483f004bc1e705675a0e65013fa2a05b300c785eef5

Direct to Patient

Clinical/Medical Providers

O&P Providers

License Revenue

Product Revenue

Total Revenue

980db2071170efedd4bc9de207ca78aa4880c663e577de3be7e7a34acf2b85a0

b828e21e3e6c00f6911d5ea9ff301e4fdfa675fa23c53ebe9a6b9361f02aaa47

Net loss (USD)

Depreciation (USD)

Stock-based compensation (USD)

Accretion of discount on short-term investments (USD)

Credit losses (USD)

Loss on equity investment (USD)

Amortization of right-of-use assets (USD)

Other non-cash charges (USD)

Net cash used in operating activities (USD)

Purchases of short-term investments (USD)

Maturities of short-term investments (USD)

Purchases of equipment (USD)

Net cash provided by (used in) investing activities (USD)

Proceeds from sale of pre-funded warrants, net of offering costs (USD)

Net settlement of vested restricted stock units to fund related employee statutory tax withholding (USD)

Net cash provided by financing activities (USD)

Effect of foreign exchange rate changes on cash (USD)

Net (decrease) increase in cash, cash equivalents and restricted cash (USD)

Accounts receivable (USD)

Inventories (USD)

Prepaid expenses and other current assets (USD)

Other assets (USD)

Accounts payable and accrued expenses (USD)

Income taxes payable (USD)

Operating lease liabilities (USD)

Deferred revenue (USD)

Cash, cash equivalents and restricted cash, beginning of period (USD)

Cash, cash equivalents and restricted cash, end of period (USD)

3014e3ee7df783b7496ace92f041186b85a9a55f8031bd1756ec3eca587dd16d

United States

Germany

Other international

China

f7ee25d6ef6e0fabfb5a4bd67bc46ad7145fddf105718eac25dfa9c86053bd4c

Product Revenue (USD, dollars)

License Revenue (USD, dollars)

Revenue (USD, dollars)

Cost of Revenue (USD, dollars)

Gross Profit (USD, dollars)

Research and Development Expenses (USD, dollars)

Selling, Clinical and Marketing Expenses (USD, dollars)

General and Administrative Expenses (USD, dollars)

Total Operating Expenses (USD, dollars)

Loss from Operations (USD, dollars)

Interest Income, Net (USD, dollars)

Loss on Equity Investment (USD, dollars)

Other (Income) Expense, Net (USD, dollars)

Loss Before Income Taxes (USD, dollars)

Income Tax Expense (USD, dollars)

Net Loss (USD, dollars)

c919c692800f44dd53b941ea484a0bb11da68fa87ea74c7c67d1cab7ad7c06d3

Myomo Inc (MYO)

Financials